Anticancer agent 259
Anticanceragent 259 (Compound 3g) is a telmisartan-derived small molecule that acts as a STAT5 pathway inhibitor, resensitizing imatinib-resistant cells with an SC50 of 1.5 μM. It is a valuable research tool for studying STAT5-dependent signaling and overcoming drug resistance in hematological cancers, as demonstrated in in vitro studies.
Product Specifications
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Molecular Formula
C30H26N2O2
Molecular Weight
446.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3041105 3x 1.0 µg
D830030K20Rik sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
Sign In for Pricing
View Details 
MR218271L3V 200 µL
Ldb3 (NM_001039072) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details